Bifidobacterium can also protect IL-10−/− mice from developing colitis [56], and it is beneficial in mice with DSS-induced colitis [57–59] and in the SAMP/Yit spontaneous model of Crohn’s-like ileitis [60]. Here, IL10 is linked to colitis.